198 related articles for article (PubMed ID: 21837360)
1. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.
Chen QY; Xu LQ; Jiao DM; Yao QH; Wang YY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ
Int J Mol Med; 2011 Nov; 28(5):769-76. PubMed ID: 21837360
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
Yuan K; Qian C; Zheng R
Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Chen QY; Zheng Y; Jiao DM; Chen FY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ; Lv GY
J Nutr Biochem; 2014 Feb; 25(2):177-85. PubMed ID: 24445042
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
Chang MH; Lee K; Lee KY; Kim YS; Kim YK; Kang JH
APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Kawasaki G; Rokutanda S; Yonezawa H; Kawakita A; Nemoto TK
Cancer Lett; 2011 Apr; 303(2):84-91. PubMed ID: 21339045
[TBL] [Abstract][Full Text] [Related]
7. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
10. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
Zhao H; Jiao Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
[TBL] [Abstract][Full Text] [Related]
11. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
[TBL] [Abstract][Full Text] [Related]
15. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
Ip CK; Cheung AN; Ngan HY; Wong AS
Oncogene; 2011 May; 30(21):2420-32. PubMed ID: 21258406
[TBL] [Abstract][Full Text] [Related]
16. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells.
Zanca C; Cozzolino F; Quintavalle C; Di Costanzo S; Ricci-Vitiani L; Santoriello M; Monti M; Pucci P; Condorelli G
J Cell Physiol; 2010 Oct; 225(1):63-72. PubMed ID: 20648624
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.
Li X; Law JW; Lee AY
Oncogene; 2012 Feb; 31(5):595-610. PubMed ID: 21706053
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
[TBL] [Abstract][Full Text] [Related]
20. Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.
Vader P; van der Meel R; Symons MH; Fens MH; Pieters E; Wilschut KJ; Storm G; Jarzabek M; Gallagher WM; Schiffelers RM; Byrne AT
Angiogenesis; 2011 Dec; 14(4):457-66. PubMed ID: 21789714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
